Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report sent to investors on Wednesday. The firm issued a hold rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Price Performance

NYSE MLSS opened at $1.26 on Wednesday. Milestone Scientific has a 12 month low of $0.54 and a 12 month high of $1.39. The company has a 50-day moving average of $1.01 and a 200-day moving average of $0.94. The company has a market cap of $98.14 million, a P/E ratio of -18.00 and a beta of 1.10.

Institutional Investors Weigh In On Milestone Scientific

Several hedge funds have recently modified their holdings of MLSS. Carnegie Investment Counsel grew its holdings in Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. World Investment Advisors LLC acquired a new stake in Milestone Scientific during the third quarter valued at approximately $91,000. Geode Capital Management LLC lifted its stake in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific in the 3rd quarter valued at about $48,000. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.